Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRI

Purpose: To assess the performance of T1 mapping and residual liver volume (RLV) on Gd-EOBDTPA-enhanced MRI in pretreatment estimation of liver function in patients with liver tumors. Indocyanine green retention rate at 15 min (ICG R-15) was used as a reference standard.Methods: Ethical approval fro...

Full description

Bibliographic Details
Main Authors: Ting Duan, Hanyu Jiang, Chunchao Xia, Jie Chen, Likunn Cao, Zheng Ye, Yi Wei, Bin Song, Jeong Min Lee
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2020.00215/full
id doaj-b39b9c982ed341649240f6a0a33f26cf
record_format Article
spelling doaj-b39b9c982ed341649240f6a0a33f26cf2020-11-25T03:17:20ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2020-05-01710.3389/fmed.2020.00215507221Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRITing Duan0Hanyu Jiang1Chunchao Xia2Jie Chen3Likunn Cao4Zheng Ye5Yi Wei6Bin Song7Jeong Min Lee8Department of Radiology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, Peking Union Medical University Hospital, Peking, ChinaDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, College of Medicine, Seoul National University, Seoul, South KoreaPurpose: To assess the performance of T1 mapping and residual liver volume (RLV) on Gd-EOBDTPA-enhanced MRI in pretreatment estimation of liver function in patients with liver tumors. Indocyanine green retention rate at 15 min (ICG R-15) was used as a reference standard.Methods: Ethical approval from the institutional review board and informed consent were obtained for this prospective study. We enrolled 155 patients with liver tumors who underwent pretreatment Gd-EOB-DTPA-enhanced MRI. T1 relaxation time before (T1-pre), 20 min after (T1-post) Gd-EOB-DTPA injection and RLV were measured. The absolute reduction (ΔT1) and reduction rate (ΔT1%) of T1 relaxation time, volume-assisted ΔT1 (ΔT1*RLV) and volume-assisted ΔT1% (ΔT1%*RLV) were calculated accordingly. The correlation of MR parameters with ICG R-15 was determined using Spearman's rank correlation analysis. Patients were classified into the normal liver function (NLF) group if their ICG R-15 levels were <10% or otherwise into the abnormal liver function (ALF) group. Receiver operating characteristic (ROC) analysis was conducted to evaluate the performances of the MR parameters in predicting ALF.Results: T1-post (r = 0.472, P < 0.001), ΔT1 (r = −0.355, P = 0.011), ΔT1% (r = −0.482, P < 0.001), RLV (r = −0.336, P < 0.001), volume-assisted ΔT1 (r = −0.458, P < 0.001) and volume-assisted ΔT1% (r = −0.522, P < 0.001) showed weak to moderate correlation with ICG R-15. The area under the ROC curves (AUROC) of volume-assisted ΔT1 in predicting ALF was 0.777, which was significantly higher than the other parameters (P < 0.05 for all).Conclusions: Combined T1 mapping and RLV on Gd-EOB-DTPA-enhanced MRI can help assess liver function with good diagnostic accuracy in patients with liver tumors before treatment.https://www.frontiersin.org/article/10.3389/fmed.2020.00215/fullGd-EOB-DTPAT1 relaxation timeresidual liver volumemagnetic resonance imagingliver function
collection DOAJ
language English
format Article
sources DOAJ
author Ting Duan
Hanyu Jiang
Chunchao Xia
Jie Chen
Likunn Cao
Zheng Ye
Yi Wei
Bin Song
Jeong Min Lee
spellingShingle Ting Duan
Hanyu Jiang
Chunchao Xia
Jie Chen
Likunn Cao
Zheng Ye
Yi Wei
Bin Song
Jeong Min Lee
Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRI
Frontiers in Medicine
Gd-EOB-DTPA
T1 relaxation time
residual liver volume
magnetic resonance imaging
liver function
author_facet Ting Duan
Hanyu Jiang
Chunchao Xia
Jie Chen
Likunn Cao
Zheng Ye
Yi Wei
Bin Song
Jeong Min Lee
author_sort Ting Duan
title Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRI
title_short Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRI
title_full Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRI
title_fullStr Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRI
title_full_unstemmed Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRI
title_sort assessing liver function in liver tumors patients: the performance of t1 mapping and residual liver volume on gd-eobdtpa-enhanced mri
publisher Frontiers Media S.A.
series Frontiers in Medicine
issn 2296-858X
publishDate 2020-05-01
description Purpose: To assess the performance of T1 mapping and residual liver volume (RLV) on Gd-EOBDTPA-enhanced MRI in pretreatment estimation of liver function in patients with liver tumors. Indocyanine green retention rate at 15 min (ICG R-15) was used as a reference standard.Methods: Ethical approval from the institutional review board and informed consent were obtained for this prospective study. We enrolled 155 patients with liver tumors who underwent pretreatment Gd-EOB-DTPA-enhanced MRI. T1 relaxation time before (T1-pre), 20 min after (T1-post) Gd-EOB-DTPA injection and RLV were measured. The absolute reduction (ΔT1) and reduction rate (ΔT1%) of T1 relaxation time, volume-assisted ΔT1 (ΔT1*RLV) and volume-assisted ΔT1% (ΔT1%*RLV) were calculated accordingly. The correlation of MR parameters with ICG R-15 was determined using Spearman's rank correlation analysis. Patients were classified into the normal liver function (NLF) group if their ICG R-15 levels were <10% or otherwise into the abnormal liver function (ALF) group. Receiver operating characteristic (ROC) analysis was conducted to evaluate the performances of the MR parameters in predicting ALF.Results: T1-post (r = 0.472, P < 0.001), ΔT1 (r = −0.355, P = 0.011), ΔT1% (r = −0.482, P < 0.001), RLV (r = −0.336, P < 0.001), volume-assisted ΔT1 (r = −0.458, P < 0.001) and volume-assisted ΔT1% (r = −0.522, P < 0.001) showed weak to moderate correlation with ICG R-15. The area under the ROC curves (AUROC) of volume-assisted ΔT1 in predicting ALF was 0.777, which was significantly higher than the other parameters (P < 0.05 for all).Conclusions: Combined T1 mapping and RLV on Gd-EOB-DTPA-enhanced MRI can help assess liver function with good diagnostic accuracy in patients with liver tumors before treatment.
topic Gd-EOB-DTPA
T1 relaxation time
residual liver volume
magnetic resonance imaging
liver function
url https://www.frontiersin.org/article/10.3389/fmed.2020.00215/full
work_keys_str_mv AT tingduan assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri
AT hanyujiang assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri
AT chunchaoxia assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri
AT jiechen assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri
AT likunncao assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri
AT zhengye assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri
AT yiwei assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri
AT binsong assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri
AT jeongminlee assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri
_version_ 1724631950702936064